Literature DB >> 1829147

Distribution of dopamine D2 receptor mRNA splice variants in the rat by solution hybridization/protection assay.

L A Snyder1, J L Roberts, S C Sealfon.   

Abstract

We investigated the distribution of the two dopamine D2 receptor mRNA splice variants in the rat using a sensitive and quantitative solution hybridization/nuclease protection assay. In all brain and endocrine regions studied, both splice variants were detected and the mRNA of the longer form (D2L) was more abundant than that of the shorter form (D2S). The lowest percentages of D2S were found in the pituitary and adrenal glands.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1829147     DOI： 10.1016/0304-3940(91)90187-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN： 0304-3940            Impact factor:   3.046


  5 in total

1.  Prominence of the dopamine D2 short isoform in dopaminergic pathways.

Authors:  Z U Khan; L Mrzljak; A Gutierrez; A de la Calle; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

2.  Antisera specific for D2 dopamine receptors.

Authors:  P L Chazot; A J Doherty; P G Strange
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

3.  Dopamine D2L Receptor Is Required for Visual Discrimination and Reversal Learning.

Authors:  Makiko Morita; Yanyan Wang; Toshikuni Sasaoka; Kinya Okada; Minae Niwa; Akira Sawa; Takatoshi Hikida
Journal:  Mol Neuropsychiatry       Date:  2016-07-21

Review 4.  Treatment of pituitary tumors: dopamine agonists.

Authors:  Gabriella Iván; Nikoletta Szigeti-Csúcs; Márk Oláh; György M Nagy; Miklós I Góth
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

5.  Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.

Authors:  J E Leysen; W Gommeren; J Mertens; W H Luyten; P J Pauwels; M Ewert; P Seeburg
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.